BIO-key Q1 2024: Revenue Up, Losses Down, Gross Margin at 86%
BIO-key reports Q1 2024 revenue surge and reduced losses, driven by major orders and cost-saving efforts, launching new password-less tech.
- Latest
- Trending
BIO-key reports Q1 2024 revenue surge and reduced losses, driven by major orders and cost-saving efforts, launching new password-less tech.
Discover the booming VRET market, driven by tech advances and mental health needs, expected to grow at a 33.90% CAGR ...
nCino unveils Banking Advisor, an AI-driven tool enhancing portfolio management, compliance, and user experiences for financial institutions.
Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.
Discover SELFGOAL, a non-parametric LLM approach using subgoal-driven Act Modules for high-level language tasks. Follow on Twitter, join ML SubReddit.
By 2030, all Baby Boomers will be older than 65. Waiting to file for retirement can increase benefit payments by ...
The vulnerability of other XDR solutions to similar attacks remains unclear. "How to Turn XDR Evil" highlights potential risks and ...
The Federal Reserve's loan program extended $165 billion on lenient terms, but stopped making new loans in March 2021 after ...
Americans have a perception of what it means to be wealthy; can you retire with $1 million? The average American ...
Reader is a groundbreaking tool that simplifies web content extraction, making it easier to analyze and understand. It represents a ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.